期刊文献+

阿托伐他汀对兔动脉粥样硬化一级预防的实验研究 被引量:4

Primary preventive effect of atrovastatin on atherosclerosis in rabbits: an experimental study
暂未订购
导出
摘要 目的:探讨阿托伐他汀对兔动脉粥样硬化的一级预防作用。方法:建立兔动脉粥样硬化模型并随机分成3组,各组兔分别于实验开始前1d及实验开始后的第4、8、12周末采血,提取血清应用日立7170型全自动生化分析仪测甘油三酯(TG)、总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-c)、高密度脂蛋白胆固醇(HDL-c),按试剂盒说明采用不同的方法分别测定高脂和正常血脂标本丙二醛(MDA)后处死动物,留取主动脉作形态学观察以及扫描、透射电镜观察。结果:阿托伐他汀可明显降低血清中TG、TC、LDL-c及MDA(P<0.05),升高HDL-c(P<0.05);阿托伐他汀可明显减轻兔主动脉动脉粥样硬化的产生。结论:阿托伐他汀具有调节血脂、抗氧化作用,可预防兔动脉粥样硬化的发生。 Objective: To probe the primary preventive effect of atrovastatin on atherosclerosis in abbits. Methods: Twenty-four male Newzeland rabbits were randomized into 3 groups: control group, cholesterol group and atrovastatin group. The blood samples were drawn from the rabbits just before the experiment and at the fourth, the eighth and the twelfth weekend of the experiment, then they were analysed the total cholesterol (TC), triglyceride (TG), high density lipoprotein cholesterol(HDL-c),low density lipoprotein cholesterol(LDL-c) by 7170 type biochemical auto-analysis apparatus and malondialdehyde (MDA) by different methods in different group. All the rabbits were sacrificed at the twelfth weekend and excised aorta for morphological observation by optical microscope and electron microscope. Results: Compared with the cholesterol group, the serum TC, LDL-c, TG and MDA were appreciably decreased(P<0.05), but the level of HDL-c were increased (P<0.05), and the atherosclerosis were obviously lightened by dietary atrovastatin. Conclusion: Atrovastatin has the efficacy of anti-oxidation and modulating lipoprotein,it can prevent the development of atherosclerosis.
出处 《山东大学学报(医学版)》 CAS 北大核心 2005年第6期487-491,共5页 Journal of Shandong University:Health Sciences
关键词 阿托伐他汀 动脉硬化 抗氧化剂 脂类 疾病模型 动物 Atrovastatin Atherosclerosis Antioxidants Lipoprotein Rabbits Disease madels,animal
  • 相关文献

参考文献6

  • 1James K Liao. Beyond lipid lowering: the role of statins in vascular protection[J]. Inter J Cardiol, 2002, 5:5~18.
  • 2Vogel RA. Cholesterol of lowering and endothelial function[J]. Am J Med, 1999, 107:479~87.
  • 3Shepherd J, Cobbe S M, Ford I. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia [J]. N Engl J Med, 1995, 333(20): 1301~1307.
  • 4Rikitake Y, Kawashima S, Takeshita S, et al. Anti-oxidative peoperties of fluvastatin, an HMG-CoA reductase inhibitor, contribute to prevention of atherosclerosis in cholesterol-fed rabbits [J]. Atherosclerosis, 2001, 154:87~96.
  • 5李飞雪.他汀类药物非降脂相关的心血管保护作用[J].医学综述,2003,9(4):250-253. 被引量:6
  • 6Mariann Harangi, Ildik6 Seres, Zsuzsa Varga, et al. Atorvastatin effect on high-density lipoprotein-associated paraoxonase activity and oxidative DNA damage[J]. Europ J Clin Pharmacol, 2004, 60:685~691.

二级参考文献20

  • 1[1]Anonymous. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study(4S) [J]. Lancet, 1994,344 (8934): 1383-1389.
  • 2[2]Osborne JA, Lento PH, Siegfried MR, et al. Cardiovascular effects of acute hypercholesterolemia in rabbits. Reversal with lovastatin treatment[J].J Clin Invest, 1989,83(2):465-473.
  • 3[3]LaRosa JC, Hunninghake D, Bush D, et al. The cholesterol facts. A summary of the evidence relating dietary fats, serum cholesterol, and coronary heart disease. A joint statement by the American Heart Association and the National Heart, Lung, and Blood Institute. AHA Medical/Scientific Statement, Special Report [ J]. Circulation 1990, 90 ( 8 ):1721-1733.
  • 4[4]Laufs U, La Fata V, Liao JK. Inhibition of 3-hydroxy-3-methylglutaryl (HMG)CoA reductase blocks hypoxia-mediated down-regulation of endothelial nitric oxide synthase[J]. J Biol Chem, 1997,272(50): 31725-31729.
  • 5[5]Laufs U, Liao JK. Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase[ J]. J Biol Chem, 1998,273 ( 37 ): 24266-24271.
  • 6[6]Endres M, Laufs U, Huang Z, et al. Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)CoA reductase inhibitors mediated by endothelial nitric oxide synthase[J]. Proc Natl Acad Sci USA 1998,95 (15):8880-8885.
  • 7[7]Lefer AM,Campboll B,Shin YK, et al.Simvastatin preserves the ischemic-repefused myocardium in normocholesterolemic rat hearts[J]. Circulation, 1999,100(2): 178-184.
  • 8[8]Prufer D, Scalia R, Lefer AM. Simvastatin inhibits leukocyte-endothelial cell interactions and protects against inflammatory processes in normocholesterolemic rats [J]. Arterioscler Thromb Vasc Biol, 1999,19 ( 12 ):2894-2900.
  • 9[9]Romano M, Mezzetti A, Marulli C, et al. Fluvastatin reduces soluble Pselectin and ICAM-1 levels in hypercholesterolemic patients:role of nitric oxide[J] .J Invest Med,2000,48(3) :183-189.
  • 10[10]Burke AP, Kolodigie FD, Frab A, et al. Healed plaque ruptures and coronary death:evidence that subclinical rupture has a role in plaque progression[J]. Circulation,2001,103(7) :936-940.

共引文献5

同被引文献45

引证文献4

二级引证文献87

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部